Martingale Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.4M Sell
534,665
-12,208
-2% -$712K 0.81% 19
2025
Q4
$29.5M Buy
546,873
+64,681
+13% +$3.11M 0.75% 29
2025
Q3
$21.7M Sell
482,192
-44,131
-8% -$2.06M 0.55% 60
2025
Q2
$24.4M Buy
526,323
+43,266
+9% +$2.12M 0.6% 52
2025
Q1
$29.5M Sell
483,057
-22,082
-4% -$1.29M 0.75% 29
2024
Q4
$28.6M Buy
505,139
+275,282
+120% +$15.4M 0.7% 34
2024
Q3
$11.9M Sell
229,857
-25,424
-10% -$1.19M 0.27% 116
2024
Q2
$10.6M Sell
255,281
-211,546
-45% -$9.47M 0.23% 128
2024
Q1
$25.3M Sell
466,827
-60,079
-11% -$3.06M 0.51% 79
2023
Q4
$27M Sell
526,906
-162,216
-24% -$8.52M 0.55% 71
2023
Q3
$40M Sell
689,122
-19,716
-3% -$1.21M 0.84% 26
2023
Q2
$45.3M Sell
708,838
-22,227
-3% -$1.49M 0.89% 23
2023
Q1
$50.7M Buy
731,065
+1,349
+0.2% +$95.1K 0.98% 13
2022
Q4
$52.5M Sell
729,716
-78,011
-10% -$5.88M 1.02% 11
2022
Q3
$57.4M Sell
807,727
-23,790
-3% -$1.73M 1.14% 9
2022
Q2
$64M Sell
831,517
-117,567
-12% -$8.95M 1.16% 9
2022
Q1
$69.3M Sell
949,084
-96,147
-9% -$6.46M 1.04% 13
2021
Q4
$65.2M Sell
1,045,231
-34,106
-3% -$2M 0.83% 28
2021
Q3
$63.9M Sell
1,079,337
-137,269
-11% -$9.04M 0.83% 24
2021
Q2
$81.3M Sell
1,216,606
-37,121
-3% -$2.42M 0.93% 21
2021
Q1
$79.1M Buy
1,253,727
+19,985
+2% +$1.24M 0.91% 23
2020
Q4
$76.5M Buy
1,233,742
+152,848
+14% +$9.4M 0.87% 27
2020
Q3
$65.2M Buy
1,080,894
+211,894
+24% +$12.8M 0.78% 28
2020
Q2
$51.1M Buy
869,000
+528,128
+155% +$31.6M 0.6% 30
2020
Q1
$19M Sell
340,872
-8,035
-2% -$491K 0.25% 136
2019
Q4
$22.4M Sell
348,907
-22,546
-6% -$1.29M 0.23% 143
2019
Q3
$18.8M Sell
371,453
-3,336
-0.9% -$157K 0.19% 153
2019
Q2
$17M Sell
374,789
-95,477
-20% -$4.45M 0.18% 156
2019
Q1
$22.4M Sell
470,266
-201,045
-30% -$10M 0.24% 130
2018
Q4
$34.9M Buy
671,311
+114,958
+21% +$6.18M 0.46% 71
2018
Q3
$34.5M Buy
556,353
+62,836
+13% +$3.73M 0.4% 86
2018
Q2
$27.3M Buy
493,517
+63,721
+15% +$3.44M 0.34% 105
2018
Q1
$27.2M Buy
429,796
+165,667
+63% +$10.7M 0.35% 99
2017
Q4
$16.2M Buy
264,129
+147,130
+126% +$9.2M 0.21% 142
2017
Q3
$7.46M Buy
+116,999
New +$6.83M 0.1% 210
2017
Q2
Sell
-30,133
Closed -$1.64M 940
2017
Q1
$1.64M Sell
30,133
-5,121
-15% -$281K 0.02% 593
2016
Q4
$2.06M Sell
35,254
-10,610
-23% -$580K 0.03% 540
2016
Q3
$2.47M Sell
45,864
-5,877
-11% -$378K 0.04% 456
2016
Q2
$3.81M Sell
51,741
-3,595
-6% -$254K 0.06% 255
2016
Q1
$3.54M Buy
55,336
+699
+1% +$44.1K 0.07% 258
2015
Q4
$3.76M Sell
54,637
-127,712
-70% -$8.44M 0.08% 242
2015
Q3
$10.8M Sell
182,349
-34,908
-16% -$2.21M 0.26% 130
2015
Q2
$14.5M Buy
217,257
+33,427
+18% +$2.2M 0.34% 92
2015
Q1
$11.9M Buy
183,830
+14,700
+9% +$920K 0.28% 118
2014
Q4
$9.98M Buy
169,130
+61,707
+57% +$3.48M 0.28% 110
2014
Q3
$5.5M Buy
107,423
+56,415
+111% +$2.82M 0.17% 181
2014
Q2
$2.48M Sell
51,008
-18,591
-27% -$916K 0.08% 277
2014
Q1
$3.62M Sell
69,599
-11,507
-14% -$612K 0.12% 208
2013
Q4
$4.31M Sell
81,106
-81,727
-50% -$4.16M 0.15% 188
2013
Q3
$7.54M Sell
162,833
-3,770
-2% -$165K 0.27% 101
2013
Q2
$7.45M Buy
+166,603
New +$7.23M 0.28% 101

Other funds holding BMY

Martingale Asset Management's BMY Position: Q1 2026 in Review

Martingale Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 2.2% in Q1 2026, selling an estimated $712K and leaving 534,665 shares worth $32.4M. The position accounts for 0.81% of the portfolio, ranked #19.

Martingale Asset Management first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $81.3M in Q2 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Martingale Asset Management held 534,665 shares of Bristol-Myers Squibb worth $32.4M as of Q1 2026.
  • Martingale Asset Management sold 12,208 Bristol-Myers Squibb shares in Q1 2026, an estimated $712K.
  • Bristol-Myers Squibb made up 0.81% of Martingale Asset Management's portfolio in Q1 2026, its #19 holding.
  • Martingale Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
  • Martingale Asset Management's Bristol-Myers Squibb position peaked at $81.3M in Q2 2021.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.